C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 267/02 (2006.01) A61K 31/55 (2006.01) A61K 31/553 (2006.01) C07D 243/12 (2006.01) C07D 491/00 (2006.01) C07D 491/04 (2006.01)
Patent
CA 2358855
The present invention relates to benzazepine derivatives and their use as alpha-V integrin receptor antagonists. More particularly, the compounds of the present invention are antagonists of the integrin receptors alphaVbeta3, alphaVbeta5, and/or alphaVbeta6 and are useful for inhibiting bone resorption, treating and preventing osteoporosis, and inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, angiogenesis, atherosclerosis, inflammation, wound healing, viral disease, tumor growth, and metastasis.
Cette invention concerne des dérivés de la benzazépine et leur utilisation en tant qu'antagonistes des récepteurs d'l'intégrine alpha-V. Plus particulièrement, les composés selon l'invention sont des antagonistes des récepteurs alphaVbeta3, alphaVbeta5, et/ou alphaVbeta6 d'intégrine. Ils servent à inhiber la résorption osseuse, à traiter et à prévenir l'ostéoporoses, à favoriser la cicatrisation des blessures, à inhiber la resténose vasculaire, la rétinophatie diabétique, a dégénérescence maculaire, l'angiogenèse, l'athérosclérose, les inflammations, les maladies virales, et la croissance des tumeurs et des métastases.
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Benzazepine derivatives as alpha-v integrin receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzazepine derivatives as alpha-v integrin receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzazepine derivatives as alpha-v integrin receptor... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1799910